Ticovac Injection
NDC Package 0069-0411-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ticovac (tick-borne encephalitis vaccine) injection is tICOVAC™ is indicated for active immunization to prevent tick-borne encephalitis (TBE). This formulation utilizes a injection delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 0069-0411 and is authorized under FDA application BLA125740.

Identification & Billing

NDC Package Code
0069-0411-10
Package Description
10 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0069-0411-01)
Product Code
0069-0411
11-Digit Billing Format
00069041110
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 2583641 - tick-borne encephalitis purified antigen 1.2 MCG in 0.25 ML Prefilled Syringe
  • RxCUI: 2583641 - 0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
  • RxCUI: 2583641 - ick-borne encephalitis purified antigen 1.2 MCG per 0.25 ML Prefilled Syringe
  • RxCUI: 2583647 - TICOVAC 1.2 MCG in 0.25 ML Prefilled Syringe
  • RxCUI: 2583647 - 0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe [Ticovac]

Clinical Specifications

Proprietary Name
Ticovac
Non-Proprietary Name
Tick-borne Encephalitis Vaccine
Substance Name
Tick-borne Encephalitis Purified Antigen (formaldehyde Inactivated)
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED) 2.4 ug/.5mL
Usage Information
TICOVAC™ is indicated for active immunization to prevent tick-borne encephalitis (TBE). TICOVAC is approved for use in individuals 1 year of age and older.

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc
Product Type
Vaccine
FDA Application #
BLA125740
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
10-25-2021
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0069-0411). Click a package code to view its specific billing and regulatory data.

0069-0411-02
1 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0069-0411-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0069-0411-10 identifies a specific commercial package of 10 syringe in 1 carton / .5 ml in 1 syringe (0069-0411-01) of Ticovac, a vaccine label labeled by Pfizer Laboratories Div Pfizer Inc. This injection is formulated for intramuscular use and contains tick-borne encephalitis purified antigen (formaldehyde inactivated) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on October 25, 2021. The current certification is valid through December 31, 2027.

How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00069041110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0069-0411-10
11-Digit CMS (5-4-2)
00069-0411-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.